Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Ones to Watch

Qualstar Corp. (NASDAQ: QBAK) is “One to Watch”

Bright Future for LTO Tape Tech, QBAK a Sector Pioneer N2Power Upside Bullish Amid Burgeoning Gaming Market 12 Months of Positive Cash Flow, Solid Long-Term Fundamentals Qualstar is one of the oldest names in data storage, with a track record … Continue reading

Posted in Ones to Watch | Leave a comment

Moleculin Biotech, Inc. (NASDAQ: MBRX) is “One to Watch”

Oncology pipeline features significant safety/efficacy advantages Lead candidate poised for FDA acceleration due to significant unmet need in AML Broad-spectrum applicability of WP1066 & WP1122 portfolios of molecules For preclinical oncology biopharma Moleculin Biotech, Inc. (NASDAQ: MBRX), the quest to … Continue reading

Posted in Ones to Watch | Leave a comment

AzurRx BioPharma, Inc. (NASDAQ: AZRX) is “One to Watch”

With more than a century of combined experience spanning the gamut from pancreas/GI tract issues in hepato-gastroenterology and infectious disease to the development of novel non-systemic (localized) therapeutic biologics and proteomics (protein engineering), the AzurRx BioPharma, Inc. (NASDAQ: AZRX) core … Continue reading

Posted in Ones to Watch | Leave a comment

FORM Holdings Corp. (NASDAQ: FH) is “One to Watch”

FORM Holdings (NASDAQ: FH) employs a relatively simple yet extremely robust targeting matrix when it comes to acquiring new development candidates. It’s really all about what this diverse holding company can bring to table, as well as how much an … Continue reading

Posted in Ones to Watch | Leave a comment

The Female Health Company / Veru Healthcare (NASDAQ: FHCO) is “One to Watch”

The Female Health Company / Veru Healthcare (NASDAQ:FHCO) has established for itself an extremely robust footing in the global public health sector via its hormone-free, latex-free FC2 Female Condom, the only FDA-approved female condom in a market forecast to deliver … Continue reading

Posted in Ones to Watch | Leave a comment

Revance Therapeutics, Inc. (RVNC) is “One to Watch”

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for use in aesthetic and therapeutic indications, including dermatology and neurology, recently announced its operating results for the third quarter of … Continue reading

Posted in Ones to Watch | Leave a comment

The Trade Desk, Inc. (TTD) is “One to Watch”

The Trade Desk, Inc. (NASDAQ: TTD) is a technology company that allows buyers to use proprietary data to better target their advertising dollars. With The Trade Desk platform, organizations are able to use fully automated and programmatic means to buy … Continue reading

Posted in Ones to Watch | Leave a comment

Daktronics, Inc. (DAKT) is “One to Watch”

Daktronics, Inc. (NASDAQ: DAKT), a company that designs, manufactures, and sells electronic display systems and related products on a global scale, has been the topic of several reports since the company announced breaking into a new 52-week high on November … Continue reading

Posted in Ones to Watch | Leave a comment

Momenta Pharmaceuticals, Inc. (MNTA) is “One to Watch”

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is a biotechnology company focused on the development of generic versions of complex drugs. The company is in the business of discovering and developing new therapies for oncology and autoimmune indications. Currently, the company has … Continue reading

Posted in Ones to Watch | Leave a comment

Matinas BioPharma Holdings, Inc. (MTNB) is “One to Watch”

Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change the way in which potent … Continue reading

Posted in Ones to Watch | Leave a comment